June 11, 2013 Janssen R&D, San Diego, Ca.
Insilicomed was one of eight breakthrough technology companies invited to give a poster presentation at the 2013 NHLBI Innovation Conference. Our presentation featured recent PASS-CRT clinical results. PASS-CRT provides clinicians with patient specific simulations as a key decision support tool that helps optimize CRT procedures and significantly improve patient outcomes.
The National Heart, Lung, and Blood Institute Innovation Conference brings together small businesses, angel investors, venture capitalists, strategic partners, and business leaders from the biotech and pharmaceutical industries. The conference features presentations by top NHLBI SBIR- funded companies with innovative technologies on the brink of commercialization, an expert panel of investors, and opportunities for partnering and networking.